Biondvax Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.01.23	BiondVax Pharma: In Vivo Data Shows NanoAb Virtually Prevents COVID-19 In Hamsters (RTTNews)
06.01.23	BiondVax's Inhaled COVID-19 Therapy Eliminated SARS-COV-2 Virus In Preclinical Study; Stock Up (RTTNews)
30.12.21	Pre-market Movers: KPRX, CTK, VGR, BVXV, NEW… (RTTNews)
28.12.21	Pre-market Movers: FTK, BVXV, PBTS, SPRB, AHPI… (RTTNews)
27.12.21	Pre-market Movers: SKM, ICCM, BVXV, AVCT, GNCA… (RTTNews)
22.12.21	BiondVax Signs Deals For Development And Commercialization Of COVID-19 Antibody Therapy; Stock Up (RTTNews)
23.06.21	BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update (PR Newswire)
22.01.21	ADMP's Symjepi Hits Walgreen's Shelves, LLY's Antibody Cuts COVID-19 Risk By 80%, FLDM On Watch (RTTNews)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
14.07.20	EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4 (RTTNews)
10.07.20	Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here (RTTNews)
07.07.20	BLU Plunges On RELIEF Data, FDA Places CLLS' Trial On Hold, IMMU Hits New High, OTIC Music To Ears (RTTNews)
20.08.18	BiondVax Moves to New Universal Flu Vaccine Manufacturing Facility (PR Newswire)
14.08.18	BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB) (PR Newswire)
19.06.18	BiondVax Receives Its First €6M Tranche Disbursement From the European Investment Bank (EIB) (PR Newswire)
29.05.18	BiondVax Announces First Quarter 2018 Financial Results (PR Newswire)
30.04.18	BiondVax Announces Fourth Quarter and Full Year 2017 Financial Results and Update (PR Newswire)
14.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...) (RTTNews)
12.04.18	BiondVax to Present at Universal Influenza Vaccines Conference (PR Newswire)
11.04.18	BiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of Its Universal Flu Vaccine in the United States (PR Newswire)
13.03.18	BiondVax Appoints CRO to Conduct Pivotal Clinical Efficacy Phase 3 Trial of Its Novel Universal Flu Vaccine Candidate (PR Newswire)
08.02.18	BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference (PR Newswire)
02.01.18	BiondVax Universal Flu Vaccine Patent Granted in India (PR Newswire)
27.12.17	BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA) (PR Newswire)
05.12.17	BiondVax's CEO Issues Letter to Shareholders (PR Newswire)
28.11.17	BiondVax Provides Third Quarter 2017 Financial Results and Update (PR Newswire)
18.09.17	BiondVax Announces Closing of $10 Million Public Offering of American Depositary Shares and Exercise of Over-allotment Option (PR Newswire)
14.09.17	BiondVax Announces Pricing of Public Offering of American Depositary Shares (PR Newswire)
13.09.17	BiondVax Announces Public Offering of American Depositary Shares (PR Newswire)
31.08.17	Dual-Listed BiondVax to Voluntarily Delist from Tel Aviv Stock Exchange (PR Newswire)
31.08.17	BiondVax Provides Second Quarter 2017 Financial Results and Update (PR Newswire)
14.08.17	BiondVax Receives Additional Grant Funding (PR Newswire)
20.07.17	BiondVax Reports Positive Phase 2b Clinical Trial Results for its Universal Flu Vaccine (PR Newswire)
18.07.17	BiondVax Signs Lease Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu Vaccine (PR Newswire)
28.06.17	BiondVax's CEO Provides First Half 2017 General Corporate Update (PR Newswire)
19.06.17	European Investment Bank (EIB) Supports Late-Stage Development and Production of BiondVax's Universal Flu Vaccine Candidate Under Horizon 2020 Initiative (PR Newswire)
30.05.17	BiondVax Announces First Quarter 2017 Financial Results and Update (PR Newswire)
16.05.17	Gainers & Losers Of May 15: CBMG, ETRM, ALNY, EGRX, ONCS... (RTTNews)
28.04.17	BiondVax Announces Fourth Quarter and Full Year 2016 Financial Results and Update (PR Newswire)
04.04.17	Gainers & Losers Of The Day: CYCC, NVCR, STDY, ACOR, OREX... (RTTNews)
30.03.17	BiondVax Approved for Grant from Israel's Ministry of Economy and Industry to Build Facility for Commercial Scale Production of its Universal Flu Vaccine (PR Newswire)
13.03.17	BiondVax Publishes Regulatory Approval Strategy for Novel Universal Flu Vaccines in Future Virology Journal (PR Newswire)
18.01.17	Gainers & Losers Of The Day: PULM, FWP, TNDM, ADHD, CNCE… (RTTNews)
12.01.17	Back to the Future: Study Published in Vaccine Journal Indicates BiondVax's Universal Flu Vaccine Candidate May Cover Strains Which Don't yet Exist (PR Newswire)
02.01.17	BiondVax Gets $2.8 Mln Investment From Check Point Chairman's Angels High Tech (RTTNews)
02.01.17	BiondVax Receives $US 2.8 Million Investment From Angels High Tech Investments Ltd. (PR Newswire)
29.11.16	BiondVax Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate is Safe and Well Tolerated (PR Newswire)
28.11.16	BiondVax Announces Third Quarter 2016 Financial Results and Update (PR Newswire)
22.11.16	Highly Pathogenic Bird Flu Spreading Across Europe and Asia; BiondVax’s Universal Flu Vaccine Candidate Also Covers these Potential Pandemic Strains (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	137.05	2.09 %	K V
UBS Group	29.03	2.00 %	K V
Logitech Intl	76.38	1.98 %	K V
Part Grp Hldg	1’266.50	1.69 %	K V
Sika	216.30	1.60 %	K V
Sonova Hldg	295.20	-0.40 %	K V
ABB	48.93	-0.47 %	K V
Nestle	74.22	-0.64 %	K V
Givaudan	3’907.00	-0.96 %	K V
Swiss Re	131.25	-1.09 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Biondvax Pharmaceuticals Ltd (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten